1. Home
  2. IMNN vs MTEK Comparison

IMNN vs MTEK Comparison

Compare IMNN & MTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMNN
  • MTEK
  • Stock Information
  • Founded
  • IMNN 1982
  • MTEK 2008
  • Country
  • IMNN United States
  • MTEK Israel
  • Employees
  • IMNN N/A
  • MTEK N/A
  • Industry
  • IMNN Biotechnology: Pharmaceutical Preparations
  • MTEK
  • Sector
  • IMNN Health Care
  • MTEK
  • Exchange
  • IMNN Nasdaq
  • MTEK Nasdaq
  • Market Cap
  • IMNN 12.9M
  • MTEK 15.1M
  • IPO Year
  • IMNN 1985
  • MTEK 2022
  • Fundamental
  • Price
  • IMNN $3.77
  • MTEK $1.25
  • Analyst Decision
  • IMNN Buy
  • MTEK
  • Analyst Count
  • IMNN 2
  • MTEK 0
  • Target Price
  • IMNN $182.61
  • MTEK N/A
  • AVG Volume (30 Days)
  • IMNN 56.4K
  • MTEK 131.0K
  • Earning Date
  • IMNN 11-13-2025
  • MTEK 09-26-2025
  • Dividend Yield
  • IMNN N/A
  • MTEK N/A
  • EPS Growth
  • IMNN N/A
  • MTEK N/A
  • EPS
  • IMNN N/A
  • MTEK N/A
  • Revenue
  • IMNN N/A
  • MTEK $3,375,716.00
  • Revenue This Year
  • IMNN N/A
  • MTEK N/A
  • Revenue Next Year
  • IMNN N/A
  • MTEK N/A
  • P/E Ratio
  • IMNN N/A
  • MTEK N/A
  • Revenue Growth
  • IMNN N/A
  • MTEK N/A
  • 52 Week Low
  • IMNN $3.56
  • MTEK $1.03
  • 52 Week High
  • IMNN $41.22
  • MTEK $6.47
  • Technical
  • Relative Strength Index (RSI)
  • IMNN 35.44
  • MTEK 38.50
  • Support Level
  • IMNN $3.56
  • MTEK $1.03
  • Resistance Level
  • IMNN $4.38
  • MTEK $1.39
  • Average True Range (ATR)
  • IMNN 0.30
  • MTEK 0.14
  • MACD
  • IMNN 0.00
  • MTEK 0.02
  • Stochastic Oscillator
  • IMNN 21.95
  • MTEK 32.84

About IMNN Imunon Inc.

Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).

About MTEK Maris-Tech Ltd.

Maris Tech Ltd is a business-to-business approach, or B2B provider of remote video, audio, telemetry acquisition, distribution, and sharing solutions and products, using high-end digital video, audio, and wireless communication technologies. It designs, develops, manufactures and commercially sells miniature intelligent video and audio surveillance and communication systems, which are offered as products and solutions for the professional as well as the civilian and home security markets.

Share on Social Networks: